Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation
- Supplementary File 1:
ZIP-Document (ZIP, 201 KiB)
Cabrera, D.; Cabello-Verrugio, C.; Solís, N.; San Martín, D.; Cofré, C.; Pizarro, M.; Arab, J.P.; Abrigo, J.; Campos, F.; Irigoyen, B.; Carrasco-Avino, G.; Bezares, K.; Riquelme, V.; Riquelme, A.; Arrese, M.; Barrera, F. Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation. Int. J. Mol. Sci. 2018, 19, 1339. https://doi.org/10.3390/ijms19051339
Cabrera D, Cabello-Verrugio C, Solís N, San Martín D, Cofré C, Pizarro M, Arab JP, Abrigo J, Campos F, Irigoyen B, Carrasco-Avino G, Bezares K, Riquelme V, Riquelme A, Arrese M, Barrera F. Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation. International Journal of Molecular Sciences. 2018; 19(5):1339. https://doi.org/10.3390/ijms19051339
Chicago/Turabian StyleCabrera, Daniel, Claudio Cabello-Verrugio, Nancy Solís, Diego San Martín, Catalina Cofré, Margarita Pizarro, Juan Pablo Arab, Johanna Abrigo, Fabián Campos, Betzabé Irigoyen, Gonzalo Carrasco-Avino, Katiuska Bezares, Valentina Riquelme, Arnoldo Riquelme, Marco Arrese, and Francisco Barrera. 2018. "Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation" International Journal of Molecular Sciences 19, no. 5: 1339. https://doi.org/10.3390/ijms19051339